From the Department of Pharmacology & Experimental Therapeutics and the Whitaker Cardiovascular Institute (F.P., K.K., A.A.F., K.R.W., M.Z.F., R.D.W.), Boston University School of Medicine, MA.
Department of Health Sciences, Sargent College (J.D.M., E.C., E.A., R.D.W.), Boston University, Boston, Massachusetts.
Hypertension. 2020 Nov;76(5):1461-1469. doi: 10.1161/HYPERTENSIONAHA.120.15928. Epub 2020 Sep 28.
Increased sympathoexcitation and renal sodium retention during high salt intake are hallmarks of the salt sensitivity of blood pressure. The mechanism(s) by which excessive sympathetic nervous system release of norepinephrine influences renal sodium reabsorption is unclear. However, studies demonstrate that norepinephrine can stimulate the activity of the NCC (sodium chloride cotransporter) and promote the development of SSH (salt-sensitive hypertension). The adrenergic signaling pathways governing NCC activity remain a significant source of controversy with opposing studies suggesting a central role of upstream α- and β-adrenoceptors in the canonical regulatory pathway involving WNKs (with-no-lysine kinases), SPAK (STE20/SPS1-related proline alanine-rich kinase), and OxSR1 (oxidative stress response 1). In our previous study, α-adrenoceptor antagonism in norepinephrine-infused male Sprague-Dawley rats prevented the development of norepinephrine-evoked SSH in part by suppressing NCC activity and expression. In these studies, we used selective adrenoceptor antagonism in male Dahl salt-sensitive rats to test the hypothesis that norepinephrine-mediated activation of the NCC in Dahl SSH occurs via an α-adrenoceptor dependent pathway. A high-salt diet evoked significant increases in NCC activity, expression, and phosphorylation in Dahl salt-sensitive rats that developed SSH. Increases were associated with a dysfunctional WNK1/4 dynamic and a failure to suppress SPAK/OxSR1 activity. α-adrenoceptor antagonism initiated before high-salt intake or following the establishment of SSH attenuated blood pressure in part by suppressing NCC activity, expression, and phosphorylation. Collectively, our findings support the existence of a norepinephrine-activated α-adrenoceptor gated pathway that relies on WNK/SPAK/OxSR1 signaling to regulate NCC activity in SSH.
在高盐摄入期间,交感神经兴奋和肾钠潴留增加是血压盐敏感性的标志。过多的交感神经系统释放去甲肾上腺素影响肾钠重吸收的机制尚不清楚。然而,研究表明,去甲肾上腺素可以刺激 NCC(氯化钠共转运蛋白)的活性,并促进 SSH(盐敏感型高血压)的发展。调节 NCC 活性的肾上腺素能信号通路仍然是一个重大争议源,相反的研究表明,上游的 α-和 β-肾上腺素受体在涉及 WNKs(无赖氨酸激酶)、SPAK(STE20/SPS1 相关脯氨酸-丙氨酸丰富激酶)和 OxSR1(氧化应激反应 1)的经典调节途径中起着核心作用。在我们之前的研究中,去甲肾上腺素输注雄性 Sprague-Dawley 大鼠中的 α-肾上腺素受体拮抗作用部分通过抑制 NCC 活性和表达来预防去甲肾上腺素引起的 SSH 的发展。在这些研究中,我们使用选择性肾上腺素受体拮抗作用在雄性 Dahl 盐敏感大鼠中测试假设,即 Dahl SSH 中 NCC 的去甲肾上腺素介导的激活是通过 α-肾上腺素受体依赖性途径发生的。高盐饮食引起 Dahl 盐敏感大鼠 NCC 活性、表达和磷酸化显著增加,这些大鼠发生 SSH。增加与 WNK1/4 动态功能障碍和 SPAK/OxSR1 活性抑制失败有关。在高盐摄入前或 SSH 确立后开始的 α-肾上腺素受体拮抗作用部分通过抑制 NCC 活性、表达和磷酸化来减轻血压。总的来说,我们的研究结果支持存在去甲肾上腺素激活的 α-肾上腺素受体门控途径,该途径依赖于 WNK/SPAK/OxSR1 信号来调节 SSH 中的 NCC 活性。